MEDP logo

MEDP

Medpace Holdings Inc.

$559.87
-$6.28(-1.11%)
60
Overall
55
Value
50
Tech
76
Quality
Market Cap
$15.47B
Volume
68.84K
52W Range
$250.05 - $626.26
Target Price
$557.27

Company Overview

Mkt Cap$15.47BPrice$559.87
Volume68.84KChange-1.11%
P/E Ratio38.3Open$566.57
Revenue$2.1BPrev Close$566.15
Net Income$404.4M52W Range$250.05 - $626.26
Div YieldN/ATarget$557.27
Overall60Value55
Quality76Technical50

No chart data available

About Medpace Holdings Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Sector: Healthcare
Industry: Diagnostics & Research

Latest News

Analysts Offer Insights on Healthcare Companies: Medpace Holdings (MEDP) and Nurix Therapeutics (NRIX)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Medpace Holdings (MEDP – Research Report) and Nuri...

Brian Anderson3 days ago
ABCD
1SymbolPriceChangeVol
2MEDP$559.87-1.1%68.84K
3
4
5
6

Get Medpace Holdings Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.